Buprenorphine, 0.6 mg/ml Injection, 20ml MDV Sterile, Rx, Vital Care Compounder, Hattiesburg, MS
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
95,089 total recalls in our database
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Mckesson Packaging Services
Labeling: Label mix-up. The inner packaging was properly labeled Omeprazole DR 40mg Capsules, but the outer secondary packaging was mislabeled Lansoprazole Delayed-Release 30mg Capsules.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility
Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
Pharmacy Plus, Inc.
Lack of Assurance of Sterility